Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04061135 · ClinicalTrials.gov registry record · NA
Neurophysiological, Behavioral, and Cognitive Networks in Movement Disorders
A NA study of Movement Disorders, sponsored by University of Alabama at Birmingham.
- Recruiting
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT04061135: Recruiting NA study of Movement Disorders, sponsored by University of Alabama at Birmingham.
NCT04061135 is a NA study of Movement Disorders that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 90 participants, below the 1,064-participant average among 26 other Movement Disorders trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04061135, a NA study of Movement Disorders, is actively recruiting participants, sponsored by University of Alabama at Birmingham.
- RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate the brain activity associated with motor and non-motor symptoms of movement disorders, including Parkinson's disease (PD) and essential tremor. These movement disorders commonly have significant non-motor features, such as depression, cognitive and memory impairment, decreased attention, speech and language disturbances, and slower processing speeds. The investigators are interested in the brain activity associated with these motor and non-motor symptoms, and propose to investigate changes in brain activity while the investigators perform recordings of the surface and deep structures of the brain, in addition to the typical recordings the investigators perform, during routine deep brain stimulation (DBS) surgery.
Primary Outcome
In the Simon task, participants are instructed to respond with a right or left button press (Right = Red, Left = Blue) according to how a word is printed on a screen ("RED" or "BLUE"), regardless of the color in which the word is printed. This is a measurement of accuracy (% correct, ranging from 0-100, with higher scores indicating better performance)
Conditions Studied
Interventions
- PROCEDURE Response Inhibition and Deep Brain Stimulation in Parkinson's disease
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2019-09-01 |
| Est. Completion | 2029-03-31 |
| Phase | NA |
What NCT04061135 shows while recruiting
NCT04061135 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 1,064-participant average among 26 other Movement Disorders trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Movement Disorders appearing as the primary indexed condition, and to 1 intervention - of which Response Inhibition and Deep Brain Stimulation in Parkinson's disease is the first listed.
NCT04061135 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT04061135 about?
NCT04061135 is a clinical study titled "Neurophysiological, Behavioral, and Cognitive Networks in Movement Disorders". The purpose of this study is to investigate the brain activity associated with motor and non-motor symptoms of movement disorders, including Parkinson's disease (PD) and essential tremor. These movement disorders commonly have significant non-motor features, such as depression, cognitive and memory ...
What is the current status of trial NCT04061135?
This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2019-09-01. Estimated completion is 2029-03-31.
What conditions does trial NCT04061135 study?
This clinical trial studies the following conditions: Movement Disorders.
What interventions are being tested in trial NCT04061135?
The interventions under investigation include: Response Inhibition and Deep Brain Stimulation in Parkinson's disease (PROCEDURE).
Who is sponsoring clinical trial NCT04061135?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04061135 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Movement Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04061135's enrollment target sits among peer trials
90 17th of 26 higher than 10 of 26 other Movement Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Movement Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neurophysiology of the Basal Ganglia, Thalamus, and Cerebellum in Patients With Movement Disorders
RECRUITING · NA
-
Analysis of Human Movement With Assistive Devices
RECRUITING · NA
-
Non-invasive BCI-controlled Assistive Devices
RECRUITING · NA
-
Moderate Versus High Volume Light-Moderate Intensity Exercise for People With Moderate Parkinson's Disease
RECRUITING · NA
-
Leg Stretching Using an Exoskeleton on Demand for People With Spasticity
RECRUITING · NA
-
Towards Restoring Complex Movement After Paralysis: Algorithm Development With Healthy Participants
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI